Gossamer Bio Inc. (GOSS)
NASDAQ: GOSS
· Real-Time Price · USD
1.28
0.04 (3.23%)
At close: Jun 16, 2025, 3:59 PM
1.30
1.17%
After-hours: Jun 16, 2025, 07:08 PM EDT
3.23% (1D)
| Bid | 1.2 |
| Market Cap | 292.08M |
| Revenue (ttm) | 124.59M |
| Net Income (ttm) | -51.24M |
| EPS (ttm) | -0.22 |
| PE Ratio (ttm) | -5.84 |
| Forward PE | -2.67 |
| Analyst | Buy |
| Ask | 1.36 |
| Volume | 1,507,882 |
| Avg. Volume (20D) | 1,548,504 |
| Open | 1.28 |
| Previous Close | 1.24 |
| Day's Range | 1.23 - 1.35 |
| 52-Week Range | 0.52 - 1.55 |
| Beta | 1.85 |
About GOSS
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol GOSS
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for GOSS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts23 hours ago
Gossamer Bio shares are trading higher after the c...
Unlock content with
Pro Subscription
5 days ago · https://www.defenseworld.net
Squarepoint Ops LLC Has $65,000 Stake in Gossamer Bio, Inc. (NASDAQ:GOSS)Squarepoint Ops LLC trimmed its stake in Gossamer Bio, Inc. (NASDAQ:GOSS – Free Report) by 51.0% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutiona...
1 month ago · seekingalpha.com
Gossamer Bio, Inc. (GOSS) Q1 2025 Earnings Conference Call TranscriptGossamer Bio, Inc. (NASDAQ:GOSS ) Q1 2025 Earnings Conference Call May 15, 2025 4:30 PM ET Company Participants Bryan Giraudo - COO & CFO Faheem Hasnain - Co-Founder, CEO, President & Chairman Richard...
